Gantalao, Romio T.

HRN: 26-95-25  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/13/2025
04/20/2025
IV
2.25g
Q6
Sepsis
Waiting Final Action 
04/19/2025
CEFIXIME 200MG (CAP)
04/19/2025
04/26/2025
PO
200MG
BID
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: